Atlas Trials

KISS Study: Kinase Inhibition With Sprycel Start up

Clinical trial NCT03193281 · UNKNOWN

Trial details

NCT number
NCT03193281
Sponsor
University of Auckland, New Zealand
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia
Start date
2017-07-17
Primary completion
2025-12-31
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.